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Abstract:  Differences in the frequency of several somatic conditions have been tentatively reported between the diagnostic sub-groups 
of pervasive developmental disorder (PDD). Retrospective cross-sectional analysis of a database was used to test these preliminary 
findings. A sample of 1189 children diagnosed with autism (n = 267), Asperger syndrome (n = 210) or autism spectrum disorder (ASD) 
(n = 712) were included for study. Parental reporting of PDD sub-groups provided a number of significant (P  0.01) differentiat-
ing developmental and behavioral items concomitant with diagnostic guidelines and anticipated level of functioning per grouping. 
Significant somatic discriminators previously reported between the sub-groups were corroborated; most notably a reported history of 
the bacterial skin infection impetigo. The majority of the somatic items identified were specifically related to a diagnosis of Asperger 
syndrome.
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Introduction
Although  categorised  as  pervasive  developmental 
disorders  (PDDs),  conditions  such  as  autism, 
Asperger syndrome and PDD-not otherwise specified 
(also known as autism spectrum disorder, ASD in the 
UK and Ireland) represent clinically discrete disor-
ders according to current diagnostic guidelines and 
practices.1,2  This,  despite  continuing  controversies 
as to the nosological validity of some diagnoses, the 
exclusivity and degree of overlap between the vari-
ous conditions and the lack of formal, genetic and/or 
biological markers as reliable, objective discrimina-
tors from each other and asymptomatic controls.3
Diagnosis  of  all  PDD  sub-groupings  currently 
resides  on  the  basis  of  observed  behaviors  and 
detailed  inspection  of  early  developmental  history 
through retrospective questioning of parents/primary 
caregivers.  The  seminal  descriptions  provided  by 
Kanner4 and Asperger5 for autism and Asperger syn-
drome (AS) respectively, implied that the unusual 
behavioral manifestations depicted were fundamen-
tal to distinguishing patients presenting with these 
conditions  from  “normally”  developing  controls. 
The focus on the overt behavioral manifestations of 
the conditions whilst crucial has nevertheless tended 
to overshadow a number of other, more somatically-
based  observations  made  by  each  author.  Kanner, 
in his original case-series for example, described a 
number of physiological aspects present in his patient 
group  including  the  presence  and  effect  of  viral 
and bacterial agents, gait and motor co-ordination 
issues and early infantile feeding problems. Some 
of these factors are, at last, becoming the focus of 
investigations.6
Several co-morbid medical and somatic factors, 
outside of the behavioral and cognitive expressions 
of the condition, have been linked to PDD. Various 
conditions have been reported to be more frequently 
present in people with PDD and their families than 
would have been expected from control groups and 
population estimates, including psoriasis,7 arthritis8 
and other more functional problems associated with 
bowel habits.9 The majority of studies examining the 
potential overlap between PDD and somatic symp-
toms/conditions have tended to rely on either focus-
ing on one specific PDD sub-grouping or combining 
results from participants with several different PDD 
diagnoses.
The frequency of various somatic factors contrasted 
across the various PDD diagnostic sub-groups has 
also been described.10 The dataset used in this study 
was derived from an electronic database of paren-
tal responses to a questionnaire. The main findings 
suggested  that  whilst  trends  in  the  developmental 
and  behavioral  presentation  of  the  various  sub-
groups  matched  expected  clinical  descriptions, 
there was variation in the reporting of a number of 
somatic features across the sub-groups. Diagnosis of 
AS seemed to confer greater susceptibility to items 
such as increased early infantile feeding problems, 
and a greater frequency of the bacterial skin disor-
der impetigo. The current paper details a follow-up 
investigation based on analyses of the original devel-
opmental, behavioral and somatic items used in the 
previous study, with a larger, independent sample of 
participants.
Methods
As previously detailed, information on participants 
diagnosed  with  PDD  are  collected  via  a  parent-
report questionnaire as part of related studies.11–14 In 
the current investigation, cross sectional analysis of 
parental  responses  to  various  questionnaire  items, 
described by Whiteley,10 pertaining to medical and 
developmental  history  and  current  abilities  were 
analysed for an independent group based on records 
received  between  December  2002  and  November 
2007 (N = 2995). A number of additional items were 
also included as part of the current investigation.
Completed records (n = 1189) for participants resi-
dent in the UK or Republic of Ireland, aged between 
3–11 chronological years and in receipt of a formal 
diagnosis of autism (n = 267), Asperger syndrome 
(n = 210) or autism spectrum disorder (ASD) (n = 712) 
[ICD  (international  statistical  classification  of  dis-
eases) codes F84.0, F84.5, F84.8] were included for 
study (Table 1). Criteria for formal diagnoses included: 
parental  indication  of  child’s  receipt  of  a  formal 
PDD diagnosis, indication of a specific categorical 
PDD diagnosis (autism, Asperger syndrome, ASD), 
recorded date of diagnosis (month/year), details of 
diagnosing clinician and place where diagnosis was 
given. Parents were also encouraged where possible 
to provide copies of the feedback provided during 
diagnostic  assessment  detailing  the  type  of  instru-
ment used during assessment and any observations Trends in PDD sub-groups
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Table 1. numbers of cases and demographics by PDD diagnostic sub-groups (parentheses for total cases show percentages 
as a function of the total number of cases included in analysis, n = 1189; all other parentheses show percentages according to 
sub-group totals). Maternal and paternal occupations show the most popular occupations according to sOC2000 codings.
  Autism As AsD
*Total cases 267 (22) 210 (18) 712 (60)
  *Males 230 (86) 193 (92) 625 (88)
  *Females 37 (14) 17 (8) 87 (12)
*Mean age (years)a 5.53 7.04 4.85
  *sD 2.38 2.22 1.89
Area of residence
  Urban 70 (26) 34 (16) 143 (20)
  suburban 117 (44) 109 (52) 342 (48)
  rural 58 (21) 59 (28) 160 (23)
  Missing responses 21 (8) 8 (4) 65 (9)
Maternal ethnicity
  White British 208 (78) 183 (87) 535 (75)
  White Irish 24 (9) 12 (6) 65 (9)
  Other White 14 (5) 12 (6) 32 (4)
  Other background 21 (8) 3 (1) 79 (11)
paternal ethnicity
  White British 204 (76) 189 (90) 537 (75)
  White Irish 25 (9) 10 (5) 63 (9)
  Other White 11 (4) 6 (3) 27 (4)
  Other background 20 (7) 5 (2) 85 (12)
  Missing responses 1 (–) – –
current maternal occupation
  At home 121 (45) 74 (35) 317 (44)
  Teaching 27 (10) 26 (12) 52 (7)
  health associates 20 (7) 10 (5) 49 (7)
  Administrative 17 (6) 13 (6) 52 (7)
  Business 11 (4) 5 (2) 28 (4)
  Management 6 (2) 11 (5) 14 (2)
  Other 64 (22) 55 (27) 166 (24)
  Missing responses 11 (4) 16 (8) 34 (5)
current paternal occupation
  Management 29 (11) 21 (10) 90 (13)
  engineering 25 (9) 16 (8) 54 (8)
  Business 19 (7) 16 (8) 58 (8)
  Construction 18 (7) 12 (6) 38 (5)
  IT 16 (6) 18 (9) 46 (6)
  Other 116 (44) 102 (47) 325 (46)
  Missing responses 44 (16) 25 (12) 101 (14)
*Mean age of participants reported by Whiteley10 (p. 6) were: autism = 5.49 years; AS = 6.72 years; AsD = 4.76 years. For maternal occupations the 
following codings have been applied: Teaching = sOC231 (Teaching professionals), health associates = sOC321 (health associate professionals), 
Administrative = sOC413 (Administrative occupations: records), Business = SOC353 (Business and finance associate professionals), Management = 
sOC113 (Functional managers). For paternal occupations the following codings have been applied: Management = sOC113, engineering = sOC212 
(engineering professionals), Business = SOC353, Construction = SOC531 (Construction trades), IT = sOC213 (Information and communication technology 
professionals).
aSignificant results of ANOVA: mean age (years) F = 90.756; d.f. = 2; P  0.0005.Whiteley et al
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made  by  the  diagnosing  clinician/s.  Details  of  the 
volume and type of supplementary evidence provided 
are shown in Table 2. Where supplementary evidence 
was provided, authors used this as confirmation of 
parental reporting accuracy of diagnosis. Independent 
confirmation of diagnoses and/or cognitive abilities 
was not performed by the authors.
Various  additional  background  data  on  parents 
and children were also collected including details of 
whether the child was fostered or adopted, and con-
firmation  of  parental  ethnicity. This  ensured  accu-
rate reporting of gestation and early developmental 
history and adequate use of English as the primary 
familial language. For items relating to early infantile 
history (pregnancy, birth, post-natal period), parents 
were  asked  to  consult  their  child’s  baby  develop-
ment book to aid accurate recall for relevant ques-
tions. Maternal and parental occupational responses 
were subsequently coded by the authors using the 
Standard Occupational Classification 2000 (SOC2000) 
schedule.15
Statistical analyses were performed using SPSS 
for Windows™ (version 14.0.1, SPSS, Chicago, IL, 
USA, 2005). Chi-squared (χ2) was used for categorical 
data responses and an analysis of variance (ANOVA) 
for continuous variables with a significance level for 
probability  (P)  set  at  0.01. The  Ethics  Committee 
at  the  University  of  Sunderland  had  approved  all 
protocols. All data collected were held in accordance 
with the 1998 Data Protection Act.
Results
Tables 1–9 show the results of the analyses carried 
out on the current dataset. Items also included as 
part of the analysis by Whiteley10 have been marked 
by a (*). No significant differences in birth month 
(χ2 = 23.482; d.f. = 22; P = 0.375; Fig. 1), area of 
residence (urban, suburban, rural), parental ethnicity 
or  parental  occupations  were  found  between  the 
groups (Table 1). Mean age at testing was signifi-
cantly different between the groups; although showing 
equivalence  with  findings  previously  reported  by 
Whiteley.10
Analysis  of  maternal  and  paternal  occupations 
based on SOC2000 showed that aside from working at 
home, the most commonly occurring maternal occu-
pations across the diagnostic groups related to teach-
ing, nursing and administrative vocations. For fathers, 
management, engineering and business-related jobs 
were similarly most prevalent. Table 2 details further 
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Figure 1. Month of birth according to PDD diagnostic sub-group including UK population birth trends per month for 2004a.
aData available from the Office for National Statistics (ONS) (Births 1938–2004). http://www.statistics.gov.uk/STATBASE/xsdataset.asp?More=Y&vlnk=4
237&All=Y&B2.x=102&B2.y=9.Trends in PDD sub-groups
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information on co-morbidity (psychiatric and genetic 
disorders), the most popular assessment instruments 
used to make a PDD diagnosis and common pharma-
cotherapies in current usage amongst the groups.
A significant difference in mean age at diagnosis 
between  the  sub-groups  was  found  (Table  2);  the 
average age for the AS group being approximately 
30 months later than for the autism and ASD group-
ings.  Significantly  more  parents  of  participants 
with  AS  also  provided  supplementary  diagnostic 
information. The use of genetic screening as part of 
the  diagnostic  process  (to  rule  out  known  genetic 
Table 2. Details of diagnosis, co-morbidities and pharmacotherapeutic usage of participants according to PDD sub-groups. 
For most common assessment instruments parentheses show percentages according to numbers providing additional 
evidence of diagnosis. In all other cases parentheses show percentages according to sub-group totals.
Autism As AsD
Mean age at diagnosis (months)a 45.91 75.19 46.37
  sD 18.53 26.22 17.80
Co-morbid diagnoses
  Learning disability 2 (1) – 2 (–)
  AD(h)D 4 (1) 13 (6) 12 (2)
  DCD/Dyspraxia – 4 (2) 4 (1)
  epilepsy/seizures 24 (9) 11 (5) 50 (7)
supplementary evidence of diagnosisb 90 (34) 97 (46) 241 (34)
Most common assessment instruments
  ADOs-g 15 (17) 6 (6) 25 (10)
  ADI-r 3 (3) 2 (2) 10 (4)
  CArs 7 (8) – 6 (2)
  DIsCO 4 (4) 7 (7) 15 (6)
genetic testing carried outc 88 (33) 30 (14) 216 (30)
  Down syndrome 1 (–) – 1 (–)
  Tuberous sclerosis – – 1 (–)
  Fragile X syndrome – – 3 (–)
  Other genetic condition 5 (2) 3 (1) 6 (1)
Pharmacotherapy usage 63 (24) 58 (28) 155 (22)
  Anti-epileptics 6 (2) 2 (1) 15 (2)
  Anti-depressants 1 (–) – –
  neuroleptics/antipsychotics 2 (1) – 3 (–)
  stimulants 2 (–) 8 (4) 5 (1)
  hypnotics/sleep-inducers 9 (3) 3 (1) 21 (3)
sleeping problems 144 (54) 118 (56) 342 (48)
  Insomniad 22 (8) 42 (20) 73 (10)
  night wakinge 90 (34) 33 (16) 209 (29)
  Excessive sweatingf 26 (10) 53 (25) 105 (15)
  Indications of nightmareg 12 (4) 26 (12) 50 (7)
aSignificant results of ANOVA: mean age at diagnosis (months) F = 186.653; d.f. = 2; P  0.0005. bSignificant results of χ2-test: additional evidence of 
diagnosis χ2 = 11.505; d.f. = 2; P = 0.003. cSignificant results of χ2-test: genetic testing carried out χ2 = 24.433; d.f. = 2; P  0.0005. dSignificant results of 
χ2-test: insomnia χ2 = 18.951; d.f. = 2; P  0.0005. eSignificant results of χ2-test: night waking χ2 = 23.812; d.f. = 2; P = 0.003. fSignificant results of χ2-test: 
excessive sweating χ2 = 22.435; d.f. = 2; P  0.0005. gSignificant results of χ2-test: indications of nightmares χ2 = 10.866; d.f. = 2; P = 0.004.
Abberviations:  AD(H)D,  Attention-Deficit  (Hyperactivity)  Disorder;  DCD,  Developmental  Co-ordination  Disorder;  ADOS-G,  Autism  Diagnostic 
Observation schedule-generic; ADI-r, Autism Diagnostic Interview-revised; CArs, Childhood Autism rating scale; DIsCO, Diagnostic Interview of 
social and Communication Disorders.Whiteley et al
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conditions)  was  less  frequently  reported  for  the 
AS  group. Analysis  of  reports  of  overall  sleeping 
problems  between  the  sub-groups  showed  no 
significant difference. Specific items such as insom-
nia,  excessive  sweating  during  sleep  and  indica-
tions of nightmare were however identified as being 
significantly  more  frequent  for  the Asperger  syn-
drome (AS) group than other sub-groupings, whilst 
episodes of night waking were reduced.
Analysis of items relating to the timing of symptom 
onset (Table 3) showed some inconsistency with pre-
viously reported findings; where no significant differ-
ence in temporal categorical bandings was previously 
reported.10 In the current dataset, parents of children 
with AS were significantly more likely to report a later 
symptom onset (especially post-24 months) than the 
autism or ASD group. This finding is confirmed where 
parents had indicated a specific age of symptom onset 
in months. The mean ages for the groups were: autism 
(n = 97) 18.7 months (SD = 10.4), Asperger syndrome 
(n = 67) 24.1 months (SD = 13.3) and ASD (n = 243) 
18.2 months (SD = 7.8). Analysis of responses using 
an ANOVA showed a significant difference between 
groups (F = 9.898; d.f. = 2; P  0.0005) despite a 
reduction  in  responses  to  this  item.  Parents  of 
children with AS were also more likely to report overt 
behavioral  problems  as  being  the  first  indicator  of 
symptom  onset  rather  than  the  more  communica-
tive items (language, eye contact) compared to other 
groups (Table 3).
Table 4 shows data regarding skills acquired prior 
to symptom onset, and details significant differences 
in items such as repeated use of single words (aside 
from ‘mummy’ and ‘daddy’), the use of 2–3 word 
phrase speech, pointing to express interest or show 
something  and  potty  training. Again  the AS  group 
showed increased acquisition of all these skills. The 
AS group also showed a significantly lower frequency 
of regression in acquired skills in agreement with the 
findings by Whiteley.10 Where there was an indication 
of a loss of previously acquired skills, the mean age 
values at which regression was reported were: autism 
(n = 112) 20.5 months (SD = 9.3) Asperger syndrome 
(n = 58) 29.2 months (SD = 15.9) and ASD (n = 280) 
21.7 months (SD = 11.2). Analysis of responses using 
an ANOVA showed a significant difference between 
groups (F = 12.426; d.f. = 2; P  0.0005). Current func-
tioning and behavior (Table 5) followed traditional 
clinical guidelines, with the AS group presenting with 
a significantly increased use of functional language in 
comparisons to other sub-groups. A greater frequency 
in the report of obsessions was also noted for this 
Table . Categorical time reports of symptom onset and first indications of problems by parents according to diagnostic 
sub-group. Parentheses show percentages according to sub-group totals.
Autism As AsD
*Categorical time of symptom onset
  *First 6 months 22 (8) 24 (11) 59 (8)
  *7–11 months 21 (8) 22 (11) 64 (9)
  *12–15 months 55 (21) 22 (11) 129 (18)
  *16–24 monthsa 117 (44) 53 (25) 295 (41)
  *Post 24 monthsb 49 (18) 83 (40) 156 (22)
  *Missing responses 3 (1) 5 (2) 8 (1)
First indication of problems
  Language problemsc 95 (36) 17 (8) 280 (39)
  eye contact problemsd 26 (10) 7 (3) 76 (11)
  Behavioral problemse 27 (10) 91 (43) 109 (15)
  Other 28 (11) 28 (13) 92 (13)
  Missing responses 98 (37) 72 (34) 206 (29)
aSignificant results of χ2-test: time of symptom onset 16–24 months χ2 = 20.135; d.f. = 2; P  0.0005. bSignificant results of χ2-test: time of symptom onset 
post 24 months χ2 = 35.639; d.f. = 2; P  0.0005. cSignificant results of χ2-test: language problems χ2 = 85.824; d.f. = 2; P  0.0005. dSignificant results of 
χ2-test: eye contact problems χ2 = 9.960; d.f. = 2; P = 0.007. eSignificant results of χ2-test: behavioral problems χ2 = 121.339; d.f. = 2; P  0.0005.Trends in PDD sub-groups
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group. Both these findings confirm the results pre-
sented by Whiteley.10
Analyses of somatic items are shown in Tables 6–9. 
The AS group were reported to show significantly 
elevated rates of contracting varicella (chicken pox) 
compared to the other sub-groups. Several other, more 
general,  somatic  factors  also  showed  differences; 
specifically in relation to ‘redness of ears’ and the 
appearance of dark circles under the eyes. Frequency 
of bowel problems and functional bowel habits are 
detailed in Table 7. Unsurprisingly, rates of achieve-
ment of bowel and bladder continence (both day and 
night)  were  significantly  higher  for  the  more  able 
AS group. Overall, 48% of the total group (autism, 
AS and ASD) were reported to show problems with 
functional bowel habits; with constipation reported in 
23% of the group. The AS sub-group were described 
as showing a more frequent indication of abdominal 
pain; although no other significant bowel symptoms 
such as bloating or distension were found to be con-
firmatory in comparison to the other groups. In terms 
of bowel habits, the majority of participants tended 
to produce stools indicative of normal bowel habits 
(snake-like  smooth,  fluffy  with  ragged  edges,  soft 
blobs with clear edges) rather than lumpy or loose 
stools; although about a fifth of all participants pro-
duced large, bulky stools. In terms of bowel habit 
problems, the autism group showed a significantly 
increased  frequency  of  undigested  food  present  in 
stools.
Table . skills acquired prior to symptom onset and reports of regression per diagnostic sub-grouping. Percentages as 
a function of total participants per sub-grouping are shown in parentheses. Percentages for Skills regressed are shown 
as a function of the number of participants who are reported to have shown a regression in acquired skills (autism = 146, 
Asperger syndrome = 76, AsD = 337).
Autism As AsD
*skills acquired prior to symptom onset
  repeated use of single words
  (aside from “Mummy”, “Daddy”)a 104 (39) 107 (51) 263 (37)
  *Language (2–3 word phrases)b 60 (23) 110 (52) 142 (20)
  *Pointing to express interest or 79 (30) 106 (51) 223 (31)
  show somethingc
  *Potty trainingd 30 (11) 72 (34) 60 (8)
  *social interest/responsiveness 128 (48) 105 (50) 298 (42)
  Crawling 153 (57) 115 (55) 429 (60)
  *Walking 197 (74) 149 (71) 498 (70)
*regression in acquired skillse 146 (55) 76 (36) 337 (47)
skill regressed
  Language regressionf 93 (64) 27 (35) 239 (71)
  eye-contactg 85 (58) 31 (41) 183 (54)
  Use of pointingh 43 (29) 8 (10) 92 (27)
  social interesti 85 (58) 30 (39) 205 (61)
  Bladder continence 10 (7) 10 (13) 21 (6)
  Bowel continence 15 (10) 16 (21) 34 (10)
  Walking 6 (4) 5 (7) 14 (4)
*Significant items reported by Whiteley10 (p. 7) for skills acquired prior to symptom onset were: language (2 or 3 word phrases), potty training and a 
regression in acquired skills.
aSignificant results of χ2-test: repeated use of single words χ2 = 18.137; d.f. = 2; P  0.0005. bSignificant results of χ2-test: use of 2–3 word phrases 
χ2 = 90.542; d.f. = 2; P  0.0005. cSignificant results of χ2-test: pointing χ2 = 29.570; d.f. = 2; P  0.0005. dSignificant results of χ2-test: potty training 
χ2 = 93.813; d.f. = 2; P = 0.007. eSignificant results of χ2-test: regression in acquired skills χ2 = 22.005; d.f. = 2; P  0.0005. fSignificant results of χ2-test: 
language regression χ2 = 36.671; d.f. = 2; P  0.0005. gSignificant results of χ2-test: eye contact χ2 = 18.881; d.f. = 2; P  0.0005. hSignificant results 
of χ2-test: use of pointing χ2 = 18.165; d.f. = 2; P  0.0005. iSignificant results of χ2-test: social interest χ2 = 21.502; d.f. = 2; P  0.0005.Whiteley et al
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Rates  of  skin  and  respiratory  complaints  are 
reported  in  Table  8  with  39%  of  the  total  group 
presenting  with  a  history  of  eczema  or  contact 
dermatitis. A history of the bacterial skin disorder 
impetigo was more frequently reported for the AS 
group; as was a history of fungal infection leading 
to athletes foot. A history of asthma was also more 
frequently noted for the AS group.
Table 9 details pre-, peri- and post-natal events per 
sub-group. Approximately 5% of all parents reported 
use of some artificial or aided methods of concep-
tion.  Other  notable  details  were  reports  of  fetal 
distress  and  emergency  caesarean  delivery  pres-
ent in approximately 20 and 25% of all participants 
respectively.  Where  there  was  information  about 
the number of weeks gestation at delivery, the mean 
values were: autism (n = 143) 39.0 weeks (SD = 3.1), 
Asperger syndrome (n = 140) 39.0 weeks (SD = 2.7) 
and ASD (n = 457) 38.8 weeks (SD = 2.6). Mean 
birth  weights  were:  autism  (n  =  50)  3385.98  g 
(SD = 662.7), Asperger syndrome (n = 57) 3414.21 g 
(SD = 633.2) and ASD (n = 238) 3315.32 g (SD = 712.2). 
Mean birth lengths were: autism (n = 73) 50.78 cm 
(SD = 7.1), Asperger syndrome (n = 84) 51.80 cm 
(SD = 8.6) and ASD (n = 277) 50.69 cm (SD = 6.9). 
There were no significant differences amongst any 
of these variables between the groups. Breastfeeding 
rates (exclusively 4 weeks) were high for all groups 
(60%–69%)  in  comparisons  to  contemporary  UK 
population  statistics  for  the  first  month  (≈55%).16 
A  significant  difference  in  rates  of  reported  early 
infantile  feeding  problems  was  found  for  the  AS 
group in agreement with result from Whiteley.10 The 
exact types of feeding problems were not however 
elucidated by any significant diagnostic difference in 
specific items measured (vomiting, projectile vomit-
ing, colic, failure to feed or reflux).
Discussion
The overlap between the presented results and those 
independently reported by Whiteley10 suggests a degree 
of consistency in the behavioral and somatic trends 
being  detailed  by  parents  of  participants  diagnosed 
with PDD using the parent-report method. The appear-
ance of differences in developmental and behavioral 
factors  particularly  in  relation  to Asperger  syndrome 
(AS)  compared  to  the  other  sub-groupings,  match 
expected differences in the development and presenta-
tion of clinical symptoms centered on the severity of 
symptoms displayed in connection with language and 
behavior. On that basis, the methods employed by the 
authors using parents as primary informers alongside 
secondary,  confirmatory  evidence  gains  credibility. 
The various somatic factors identified as significant 
Table . reported frequency of current skills per diagnostic sub-grouping. Parentheses show percentages as a function 
of sub-group totals.
Autism As AsD
*Categorical current languagea
  *no current use of language 71 (27) 1 (–) 125 (18)
  Use of single words only
  (not including “mummy”, “daddy”) 58 (22) – 144 (20)
  *Use of 2–3 word phrase speech 123 (46) 192 (91) 418 (59)
  Missing responses 15 (6) 17 (8) 25 (3)
*Current behavior
  *Presence of routines/rituals
  (compulsive in nature) 172 (64) 136 (65) 418 (58)
  Missing responses (routines) 14 (5) 14 (7) 23 (3)
  *Obsessionsb 158 (59) 180 (86) 457 (64)
  Missing responses (obsessions) 12 (4) 5 (2) 31 (4)
*Significant items reported by Whiteley10 (p. 8) for current skills variables were: categorical current language and the presence of obsessions.
asignificant results of χ2-test: current language χ2 = 138.845; d.f. = 6; P  0.0005. bsignificant results of χ2-test: obsessions χ2 = 41.199; d.f. = 2; 
P  0.0005.Trends in PDD sub-groups
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Table . Frequency of reported viral infections, ear/hearing problems and eye/vision problems per diagnostic sub-grouping. 
Parentheses show percentages as a function of sub-group totals.
Autism As AsD
*history of viral infection
  encephalitis 2 (1) – 2 (–)
  Meningitis 3 (1) 2 (1) 6 (1)
  *Varicellaa 128 (48) 131 (62) 355 (50)
  *Measles 6 (2) 9 (4) 12 (2)
  *Mumps 3 (1) 1 (1) 2 (–)
  *Rubella 2 (1) 5 (2) 8 (1)
  Other 40 (15) 28 (13) 102 (14)
history of ear problems
  hearing loss 29 (11) 18 (9) 40 (6)
  *recurrent ear infection (otitis) 58 (22) 51 (24) 141 (20)
  redness of earsb 71 (27) 82 (39) 180 (25)
  *Use of grommets/tubes 38 (14) 21 (10) 82 (12)
  glue ear/blockage 10 (4) 4 (2) 24 (3)
history of eye/vision problems
  Loss of sight in both eyes – – 1 (–)
  Loss of sight in one eye 2 (1) 2 (1) –
  Use of peripheral vision 21 (8) 7 (3) 68 (10)
  Dark rings around the eyesc 72 (27) 85 (40) 195 (27)
  squint 31 (12) 16 (8) 58 (8)
  Myopia 2 (1) 3 (1) 4 (1)
  Presbyopia 2 (1) 7 (3) 10 (1)
Varicella—chicken pox; myopia—near-sightedness; presbyopia—loss of flexibility in crystalline lens of the eye.
aSignificant results of χ2-test: history of viral infection—varicella χ2 = 12.280; d.f. = 2; P = 0.002. bSignificant results of χ2-test: redness of ears χ2 = 15.585; d.f. = 2; 
P  0.0005. cSignificant results of χ2-test: dark rings around the eyes χ2 = 14.481; d.f. = 2; P = 0.001.
differentiators in both studies, particularly in connection 
to the AS group, likewise gather merit; this, despite no 
confirmatory clinical investigation of symptoms being 
carried out in the current investigation.
As  per  the  findings  of  Whiteley,10  there  was  a 
significant  difference  in  the  age  of  participants 
between the various PDD sub-groups, with the AS 
group presenting at an older mean age than the other 
groupings. A robust explanation for this difference 
can be found in the developmental and behavioral 
data obtained during the current study. This suggested 
that in comparison to the autism and ASD groups, the 
AS cohort presented with a later time of symptom 
onset, less indications of early problems in core areas 
such as language and eye contact, an increased likeli-
hood of achieving normal developmental milestones 
prior to diagnosis and fewer reports of regression in 
previously acquired skills. The accompanying finding 
of a significant difference in mean age at diagnosis 
between the groups (Table 2) is also supportive and 
consistent  with  other  findings  reporting  disparity.17 
These  observations  combined  with  findings  of 
wide variations in current language skills (Table 5) 
according to diagnostic groups; the AS group almost 
unanimously presenting with 2–3 word phrase speech 
in comparison to the other sub-groups, although also 
presenting with significantly more behavioral prob-
lems such as obsessionality. This would tend to show 
agreement with other clinical descriptions of Asperger 
syndrome where communication in the form of syn-
tactical speech are reported as normal in comparison 
to autism.18Whiteley et al
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Table . Frequency of reported bowel habits and problems per diagnostic sub-grouping. Parentheses show percentages 
as a function of sub-group totals.
Autism As AsD
*Full bladder continence achieveda 124 (46) 166 (79) 344 (48)
*Full bowel continence achievedb 121 (45) 188 (89) 361 (51)
*Problem with bowel habits present 125 (47) 119 (57) 327 (46)
  *Diarrhea 44 (16) 34 (16) 105 (15)
  *Constipation 61 (23) 58 (28) 157 (22)
  *Alternating diarrhea/constipation 43 (16) 41 (19) 104 (15)
  *Undigested food in stoolsc 50 (19) 23 (11) 82 (11)
  *Blood in stools 7 (3) 9 (4) 17 (2)
  *Mucus in stools 26 (10) 13 (6) 63 (9)
Type of stool reported
  s1. separate hard lumps (nut like) 55 (21) 37 (18) 164 (23)
  s2. sausage shaped and lumpy 54 (20) 41 (19) 147 (21)
  s3. sausage shaped with cracks 30 (11) 37 (18) 109 (15)
  s4. snake-like smooth 92 (34) 74 (35) 230 (32)
  S5. Soft blobs with clear edges 27 (10) 17 (8) 64 (9)
  s6. Fluffy with ragged edges 61 (23) 50 (24) 157 (22)
  s7. Watery with no solids 33 (12) 12 (6) 64 (9)
  Frothy stools 15 (6) 7 (3) 27 (4)
  Large, bulky stools 47 (18) 42 (20) 123 (17)
  Other stools nOs 29 (11) 8 (4) 70 (10)
Manual help with defecation 16 (6) 11 (5) 41 (6)
general color of stools
  Light brown 146 (55) 95 (45) 375 (53)
  Dark brown 104 (39) 83 (39) 291 (41)
  Black stools 12 (4) 5 (2) 28 (4)
  Yellow, sand coloured 67 (25) 38 (18) 182 (26)
  green stools 18 (7) 6 (3) 36 (5)
number of bowel movements
  1 per week 4 (1) 6 (3) 12 (2)
  2 per week 8 (3) 5 (2) 18 (2)
  3 per week 10 (4) 12 (6) 32 (4)
  4 per week 23 (9) 13 (6) 59 (8)
  5–15 per week 128 (48) 102 (49) 369 (52)
  More than 15 per week 23 (9) 8 (4) 62 (9)
  Missing responses 71 (27) 63 (30) 159 (22)
(Continued)Trends in PDD sub-groups
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The  results  suggest  that  a  diagnosis  of  AS,  in 
particular,  may  potentially  confer  an  increased 
susceptibility to a number of somatic conditions not 
previously  linked  to  clinical  definitions  of  symp-
toms. That being said we are not able to rule out a 
purely epiphenomenal relationship to such conditions 
at this time. There also remains a degree of contro-
versy regarding the nosological validity of Asperger 
syndrome  (AS)  as  a  distinct  clinical  condition. 
Despite incorporation into the most recent diagnos-
tic  classification  systems,  debate  still  continues  as 
to whether AS is truly distinguishable from autism 
associated with higher levels of cognitive ability.19 
Diagnosis  of  AS  is  normally  hierarchical  rather 
than explicit. Exclusion of other conditions such as 
childhood autism is first undertaken and, assuming 
that other criteria are not met, for schizophrenia for 
example,  so  AS  is  diagnosed.  Asperger’s  original 
description of the condition5 did not decree specific 
diagnostic criteria. This combined with the relatively 
late arrival of AS as a formal diagnostic entity into 
clinical classifications has led to a number of alter-
native schedules being developed. Comparisons of 
some of these schedules20 with more formal diagnostic 
Table . (Continued)
Autism As AsD
Other bowel problems
  Bloating 37 (14) 29 (14) 80 (11)
  Distension (pot-bellied) 65 (24) 44 (21) 167 (23)
  Indications of pain on passing stools 37 (14) 46 (22) 121 (17)
  Indications of abdominal paind 50 (19) 68 (32) 136 (19)
  Flatulence (frequent wind) 69 (26) 65 (31) 191 (27)
NOS—Not Otherwise Specified. Types of stool reported show the 7 categories of stool based on the Bristol Stool Chart33 (s1–s7). stools s1 and s2 
indicate constipation, S3 and S4 indicate the ideal stool, S5-S7 show a tendency towards diarrhea or urgency.
*Significant items reported by Whiteley10 (p. 8) for clinical features variables were: achievement of bowel and bladder continence. no other details on 
functional bowel habits were provided.
aSignificant results of χ2-test: full bladder continence achieved χ2 = 67.164; d.f. = 2; P  0.0005. bSignificant results of χ2-test: full bowel continence 
achieved χ2 = 113.608; d.f. = 2; P  0.0005. cSignificant results of χ2-test: undigested food in stools χ2 = 9.840; d.f. = 2; P = 0.007. dSignificant results of 
χ2-test: indications of abdominal pain χ2 = 22.949; d.f. = 2; P  0.0005.
Table . Frequency of reported skin problems/conditions and respiratory problems/conditions per diagnostic sub-grouping. 
Parentheses show percentages as a function of sub-group totals.
Autism As AsD
*history of skin complaints
  *eczema/contact dermatitis 104 (39) 98 (47) 267 (37)
  *Acne 2 (1) 2 (1) 2 (–)
  Psoriasis – 1 (–) 1 (–)
  *Athletes foota 3 (1) 14 (7) 11 (1)
  *Impetigob 25 (9) 37 (18) 56 (8)
history of respiratory complaints
  Asthma c 36 (13) 50 (24) 106 (15)
  Wheeze 29 (11) 23 (11) 47 (7)
  hayfever 4 (1) 3 (1) 4 (1)
  UrTI 11 (4) 8 (4) 16 (2)
URTI—Upper Respiratory Tract Infection. *Significant item reported by Whiteley10 (p. 8) for clinical features variables is: impetigo.
aSignificant results of χ2-test: athletes foot χ2 = 20.770; d.f. = 2; P  0.0005. bSignificant results of χ2-test: impetigo χ2 = 17.326; d.f. = 2; P  0.0005. cSignificant 
results of χ2-test: asthma χ2 = 11.164; d.f. = 2; P = 0.004.Whiteley et al
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Table . Frequency of pre-, peri-, and post-natal events per diagnostic sub-grouping. Parentheses show percentages as a 
function of sub-group totals. Percentages for specific items headed under Infant feeding problems are shown as a function of 
the number of participants who were reported to have shown early feeding problems (autism = 103, Asperger syndrome = 118, 
AsD = 318).
Autism As AsD
Artificial methods of conception 10 (4) 10 (5) 35 (5)
*Pre- and peri-natal factors
  Maternal infection
  during pregnancy 26 (10) 11 (5) 54 (8)
  gestational diabetes 1 (–) 2 (1) 1 (–)
  hyperemesis gravidarum – 1 (–) 4 (1)
  high maternal blood pressure 3 (1) – 10 (1)
  *Fetal distress 55 (21) 57 (27) 135 (19)
  *emergency c-section 44 (16) 37 (18) 119 (17)
  *Hypoxia/anoxia 8 (3) 5 (2) 14 (2)
  *Pre-eclampsia 16 (6) 17 (8) 37 (5)
  Breech presentation 6 (2) 5 (2) 20 (3)
Post-natal
  *Jaundice 60 (22) 53 (25) 142 (20)
  *Anti-D administered 37 (14) 28 (13) 86 (12)
  *Breastfed (4 weeks) 161 (60) 144 (69) 463 (65)
*Infant feeding problemsa 103 (39) 118 (56) 318 (45)
  Vomiting 27 (26) 32 (27) 83 (26)
  Projectile vomiting 23 (22) 17 (14) 41 (13)
  Colic 47 (46) 61 (52) 150 (47)
  Failure to feed 8 (8) 16 (14) 39 (12)
  Reflux 8 (8) 9 (8) 27 (8)
  Other problem nOs 8 (8) 13 (11) 45 (14)
Hyperemesis Gravidarum—morning sickness; Anti-D—Anti-D Immunoglobulin D. *Significant item reported by Whiteley (2004a) (p. 8) for pre-, peri- and 
post-natal events variables is: infant feeding problems.
aSignificant results of χ2-test: Infant feeding problems χ2 = 15.170; d.f. = 2; P = 0.001.
systems  show  both  similarities  and  differences; 
primarily illustrated by how narrow the concept of AS 
is defined and how closely they relate to the original 
descriptions provided by Asperger.21 Despite nearly 
half of all participants with AS providing supplemen-
tary evidence of diagnosis, none of the most com-
monly used assessment instruments provided were 
AS specific.
Examination  of  the  early  descriptions  for  both 
autism and Asperger syndrome imply that possible 
co-morbidity  with  somatic  symptoms  may  not  be 
a  new  phenomenon.  Kanner4  noted  in  his  original 
descriptions that several of his patients presented with 
co-morbid physical ailments such as ‘Alfred’ who had 
often been kept in bed due to “chickenpox, strepto-
coccus infection [and] impetigo” (p. 234). Indeed, the 
continued association between AS and the bacterial 
skin disorder impetigo, predominantly caused by group 
A  beta-hemolytic  Steptoccocus  or  Staphylococcus 
aureus  remains  an  interesting  finding.  Both  the 
current study and the previous results presented by 
Whiteley,10  reported  a  stable  incidence  of  18%  of 
participants with AS who had a history of infection 
(although  no  additional  information  regarding  the 
type of impetigo, bullous or nonbullous, is available). 
This figure compares with UK and European estimates Trends in PDD sub-groups
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of between 2%–3% for the pediatric population.22,23 
Although the epidemiology of impetigo is still under 
investigation,  factors  such  as  hygiene,  seasonality 
and social factors related to crowding are thought to 
increase the risk of contracting the bacteria causative 
of the disease. Improper hand-washing, pica (eating 
on non-edible substances) and a greater propensity 
to  handling  feces  (i.e.  smearing)  are  also  thought 
to increase the risk of contracting such infections; 
behaviors that would not necessarily be associated 
to  any  greater  degree  with  the  higher-functioning 
AS group in comparison to the other, more severely 
affected sub-groups.
The alternative suggestion as to the increased risk 
of infection for the AS group may lie in differences 
in the way that the immune system deals with such 
infections. Several reports on the potential for inherent 
problems associated with the eradication of viruses and 
bacteria in PDD have been published.24 The involve-
ment of the immune system in PDD is complex, with a 
number of themes emerging centered on autoimmunity, 
the presence of pro-inflammatory features and immu-
nodeficiency. The primary immune response will tend 
to be inflammatory; normally focused at the various 
barriers of the body such as skin, gastrointestinal (GI) 
tract or lungs where pathogens first gain entry. Given 
then the additional findings of a significantly increased 
frequency of inflammatory respiratory conditions such 
as asthma again with the AS group, one could assume 
a potential connection may be pertinent.
Several other somatic findings for the AS group 
also merit similar discussion. Reports indicative of an 
increased frequency of “redness of the ears” and dark 
rings  around  the  eyes  are  important  observations, 
despite not carrying any obvious associated disease 
state. Dark rings around the eyes could for example 
become apparent as a function of lack of sleep or poor 
sleep quality; factors that have been reported specifi-
cally in connection to AS.25 Indeed, insomnia and indi-
cations of nightmare were more frequently reported 
for  the  AS  group  alongside  reports  of  excessive 
sweating during sleep. What is not so easy to deduce 
from this argument are the findings of significantly 
reduced  levels  of  night  waking  amongst  the  AS 
group; indicating that whilst initially getting to sleep 
may be a problem, this group would be less likely to 
wake frequently during the night and show disturbed 
sleep  patterns.  One  alternative  explanation  for  the 
issue of sleep deprivation is again a potential role for 
the immune system. Several authors have reported on 
the issue of dark rings under the eyes as being akin 
to allergic shiners;26 whereby discoloration under the 
eyes  is  representative  of  atopy  or  allergic  disease. 
Another possible association relates to the role of sul-
phate in PDD.27 In the absence of any corresponding 
biochemical measures in the current study however, 
all these possibilities must remain speculative.
Although  not  fully  elucidated,  the  increased 
frequency of infantile feeding problems noted for the 
AS group is another interesting finding. When compar-
ing responses for all three groups on this item, reported 
early feeding problems actually decrease in frequency 
according to the expected increasing severity of symp-
toms by grouping. Previous explanations have been 
provided for childhood feeding problems including 
fine motor control problems associated with muscle 
control of the tongue and mouth.28 This also fits in with 
other association made specifically between AS and 
motor co-ordination disorder such as Developmental 
Co-ordination Disorder (DCD)/dyspraxia.6 The issue 
however  is  that  such  explanations  have  tended  to 
reflect problems with older children who have already 
been  introduced  to  solid  foods.a  One  therefore  has 
to  question  whether  such  problems  could  manifest 
at an earlier age or whether other factors such as the 
food provided for the infant, based on either breast- 
or infant formula milk, may be exerting a potential 
physiological effect. Research has already begun to 
implicate the removal of casein (the primary protein 
of milk) from the diet of children with PDD as being 
of potential benefit in terms of a reduction of behav-
ioral and somatic symptoms.29 It may be possible that 
such early feeding problems are reflective of an under-
lying allergy or intolerance to such foodstuffs.
In a similar vein, a potential role for gastrointestinal 
(GI) factors in PDD is still the topic of some debate. 
Functional  GI  problems  such  as  constipation  and 
diarrhea tend to be more frequently diagnosed in 
people with a neurological or learning disability than 
in asymptomatic populations30 although no definitive 
explanation has been provided to account for this 
finding. Forty-eight percent of the total PDD group 
in the present study were reported to present with 
aThe questionnaire item used as part of the current study explicitly asks about 
problems with feeding as a young baby rather than young child.Whiteley et al
1  Autism Insights 2009:1
problems  in  functional  bowel  habits,  with  nearly 
a quarter (23%) described as having constipation. 
This contrasts with totals of 20% and 17% respec-
tively from the previous report.10 No one particular 
group seemed to demonstrate any distinct pattern of 
functional bowel habit problems despite individual 
items based on indications of abdominal pain and 
undigested food in the stools showing differences.
A  number  of  issues  regarding  the  methodology 
employed in the current study require comment. Aside 
from the examination of responses for the PDD sub-
groups, we have not included data from any other 
control group, either based on asymptomatic or learn-
ing  disabled  participants,  as  potential  comparators. 
Although such investigations were not a primary aim 
of the study, they would nevertheless have provided 
important information about responses to the ques-
tionnaire items outside of the target group. The basis 
for study recruitment, as part of related investigations, 
is another point in question. One cannot guarantee 
that participants are necessarily representative of the 
population given the “dietary/biological” focus of the 
investigations from which the current study is drawn. 
Indeed,  it  may  have  encouraged  a  disproportionate 
number of participants to join who share specific views 
on the role of physiological factors in PDD. Given 
however, that most of the somatic items reported as 
being significantly different between the sub-groups 
will  require  some  form  of  clinical  diagnosis  (e.g. 
impetigo, asthma) and/or pharmacotherapeutic use for 
treatment, one cannot wholly ascribe results to infor-
mant attribution or any societal influences. Future use 
of proactive, formal clinical diagnostic assessment for 
such somatic conditions would address such an issue.
The  significant  difference  in  chronological  age 
between the PDD sub-groups over the study period 
combined with a lack of data regarding reported onset 
for specific somatic factors represent potential sources 
of bias to our study results. The mean age of the AS 
group was approximately 1½–2 years older than that 
of the average age of the other cohorts during the 
investigation, indicating a greater period of ‘risk’ time 
and opportunity for the AS group to develop specific 
conditions or infections over the other groups. This is 
particularly true when examining rates of asthma and 
wheezing illnesse in the general population accord-
ing to age.31 To counter this argument, age-specific 
incidence  rates  for  chickenpox  for  example,  have 
shown an increased likelihood of contracting the virus 
between 0–4 years; thereafter declining with increas-
ing age.32 Age-specific incidence rates for impetigo 
likewise show the 4–5 year age-group to be most at 
risk.23 Peak exposure periods for most somatic items 
were therefore covered by the participant age ranges 
included.
The use of parents as primary reporters is always 
subject to several potential forms of bias. Control-
ling for country of residence and parental ethnicity 
as well as using additional evidence of diagnosis and 
assessment  as  a  confirmation  of  accuracy,  reduces 
the potential for reporting bias or omissions on the 
basis of informant characteristics. Whilst problems 
with retrospective recall can never be ruled out in 
such study designs, the low mean age of participants 
at time of information gathering and the finite ceiling 
age of the sample group also go some way to mini-
mize the potential impact on reporting. The use of an 
independent sample, large participant numbers com-
bined with a stringent significance threshold of prob-
ability (P  0.01) in the current study go some way to 
balancing out the potential biases that accompany the 
use of parents as primary information providers.
conclusion
Parental reporting of the diagnostic sub-groups of 
PDD provided a number of significant discriminat-
ing  items  concomitant  with  current  clinical  diag-
nostic guidelines and anticipated level of cognitive 
functioning. The confirmation of additional somatic 
factors  more  frequently  attributed  to  a  diagnosis 
of Asperger syndrome suggests the potential for a 
greater susceptibility to specific physiological prob-
lems for patients with this diagnosis outside of diag-
nostic developmental and behavioral indices. Further 
clinical investigations are required to rule out a purely 
epiphenomenal relationship.
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